GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (OTCPK:RCDTF) » Definitions » Total Assets

Recordati SpA (Recordati SpA) Total Assets : $4,589 Mil (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Recordati SpA Total Assets?

Recordati SpA's Total Assets for the quarter that ended in Dec. 2023 was $4,589 Mil.

Warning Sign:

If a company builds assets at 14.1% a year, faster than its revenue growth rate of 8.7% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Recordati SpA's average Total Assets Growth Rate was 7.30% per year. During the past 3 years, the average Total Assets Growth Rate was 16.50% per year. During the past 5 years, the average Total Assets Growth Rate was 14.10% per year. During the past 10 years, the average Total Assets Growth Rate was 13.60% per year.

During the past 13 years, Recordati SpA's highest 3-Year average Total Assets Growth Rate was 24.70%. The lowest was 2.80%. And the median was 12.60%.

Total Assets is connected with ROA %. Recordati SpA's annualized ROA % for the quarter that ended in Dec. 2023 was 8.12%. Total Assets is also linked to Revenue through Asset Turnover. Recordati SpA's Asset Turnover for the quarter that ended in Dec. 2023 was 0.13.


Recordati SpA Total Assets Historical Data

The historical data trend for Recordati SpA's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recordati SpA Total Assets Chart

Recordati SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,121.03 3,298.85 3,182.15 4,236.04 4,589.02

Recordati SpA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,263.46 4,559.47 4,516.07 4,589.02 -

Recordati SpA Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Recordati SpA's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=1839.032+2749.988
=4,589

Recordati SpA's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (Q: Dec. 2023 )+Total Liabilities (Q: Dec. 2023 )
=1839.032+2749.988
=4,589

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Recordati SpA  (OTCPK:RCDTF) Total Assets Explanation

Total Assets is connected with ROA %.

Recordati SpA's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=369.56/( (4516.073+4589.02)/ 2 )
=369.56/4552.5465
=8.12 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Recordati SpA's Asset Turnover for the quarter that ended in Dec. 2023 is

Asset Turnover
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=573.781/( (4516.073+4589.02)/ 2 )
=573.781/4552.5465
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Recordati SpA Total Assets Related Terms

Thank you for viewing the detailed overview of Recordati SpA's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Recordati SpA (Recordati SpA) Business Description

Traded in Other Exchanges
Address
Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment, which includes the production of active ingredients.

Recordati SpA (Recordati SpA) Headlines

From GuruFocus

Recordati: Isturisa® (Osilodrostat) Approved In The U.S.

By PRNewswire PRNewswire 03-09-2020